Related Experiment Video
Updated: Jul 6, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Genetic alterations in gynecological malignancies
M Krkavcová1, N Jancárková, M Janashia
1Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University Prague and General Teaching Hospital Prague, Apolinarska 18, Prague, Czech Republic.
Genetic alterations in ovarian and cervical cancer cells were analyzed. Younger ovarian cancer patients showed more chromosomal rearrangements, and proliferation markers correlated with prognosis.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Ovarian and cervical cancers exhibit distinct histopathological and clinical characteristics.
- Understanding genetic alterations is crucial for determining cancer prognosis and treatment strategies.
Purpose of the Study:
- To investigate genetic alterations in ovarian and cervical cancer cells.
- To correlate these alterations with histopathological and clinical parameters.
- To identify prognostic significance and differences between these cancer types.
Main Methods:
- Study included 60 ovarian cancer and 20 cervical cancer patients.
- Histological type, grade, MIB-1, and p53 expression were assessed.
- Conventional and molecular methods were used for genetic testing, with statistical analysis (ANOVA, I2 test).
Main Results:
- Ovarian cancer patients with extensive chromosomal rearrangements were significantly younger.
- Distinct genetic findings were observed: 22q deletion in 36% of ovarian cancers; chromosome 2 amplifications and deletions of 10, 11p, and 21q in cervical cancers.
- Higher MIB-1 expression correlated with high p53 HSCORE.
Conclusions:
- Genetic alterations and proliferation markers significantly impact prognosis in ovarian and cervical cancers.
- Younger women with ovarian tumors showed correlations between genetic changes and unfavorable outcomes.
- Specific genetic alterations identified may serve as biomarkers for these gynecological cancers.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

